Abraxane 250 mg Polvere per la preparazione di una Infusionssuspension

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

active_ingredient:

complexus paclitaxeli e albumini humani, paclitaxelum

MAH:

Celgene GmbH

ATC_code:

L01CD01

INN:

complexus paclitaxeli and albumini humani, paclitaxelum

pharmaceutical_form:

Polvere per la preparazione di una Infusionssuspension

composition:

complexus paclitaxeli e albumini humani 300 mg e paclitaxelum 5 mg corrisp. paclitaxelum 250 mg, albuminum humanum, pro vitro.

class:

A

therapeutic_group:

Synthetika

therapeutic_area:

Carcinoma della mammella, l'Adenocarcinoma del Pancreas, del non-tumori polmonari a piccole carcinoma polmonare

authorization_date:

2014-08-26